Jpmorgan Chase & CO Ani Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 422,750 shares of ANIP stock, worth $37.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
422,750
Previous 268,050 57.71%
Holding current value
$37.3 Million
Previous $14.8 Million 91.02%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$53.93 - $68.36 $8.34 Million - $10.6 Million
154,700 Added 57.71%
422,750 $28.3 Million
Q4 2024

Feb 12, 2025
SELL
$53.35 - $61.74 $15.3 Million - $17.7 Million
-286,785 Reduced 51.69%
268,050 $14.8 Million
Q3 2024

Dec 26, 2024
BUY
$54.33 - $65.72 $18.5 Million - $22.4 Million
340,854 Added 159.29%
554,835 $33.1 Million
Q3 2024

Nov 08, 2024
BUY
$54.33 - $65.72 $18.5 Million - $22.4 Million
340,854 Added 159.29%
554,835 $33.1 Million
Q2 2024

Dec 26, 2024
SELL
$58.53 - $68.82 $20 Million - $23.5 Million
-340,854 Reduced 61.43%
213,981 $13.6 Million
Q2 2024

Aug 12, 2024
SELL
$58.53 - $68.82 $1.07 Million - $1.25 Million
-18,209 Reduced 7.84%
213,981 $13.6 Million
Q1 2024

Dec 26, 2024
SELL
$54.2 - $69.69 $17.5 Million - $22.5 Million
-322,645 Reduced 58.15%
232,190 $16.1 Million
Q1 2024

May 10, 2024
BUY
$54.2 - $69.69 $442,651 - $569,158
8,167 Added 3.65%
232,190 $16.1 Million
Q4 2023

Dec 26, 2024
SELL
$48.72 - $65.43 $16.1 Million - $21.6 Million
-330,812 Reduced 59.62%
224,023 $12.4 Million
Q4 2023

Feb 12, 2024
BUY
$48.72 - $65.43 $6.34 Million - $8.52 Million
130,210 Added 138.8%
224,023 $12.4 Million
Q3 2023

Nov 14, 2023
BUY
$50.28 - $64.61 $130,778 - $168,050
2,601 Added 2.85%
93,813 $5.45 Million
Q2 2023

Aug 11, 2023
BUY
$37.29 - $53.83 $1.78 Million - $2.57 Million
47,673 Added 109.49%
91,212 $4.91 Million
Q1 2023

May 18, 2023
BUY
$37.61 - $45.72 $367,186 - $446,364
9,763 Added 28.91%
43,539 $1.73 Million
Q1 2023

May 11, 2023
SELL
$37.61 - $45.72 $200,686 - $243,961
-5,336 Reduced 13.64%
33,776 $1.34 Million
Q4 2022

Feb 13, 2023
BUY
$31.9 - $41.95 $113,085 - $148,712
3,545 Added 9.97%
39,112 $1.57 Million
Q3 2022

Nov 14, 2022
BUY
$29.83 - $38.01 $4,653 - $5,929
156 Added 0.44%
35,567 $1.14 Million
Q2 2022

Aug 11, 2022
BUY
$23.09 - $33.46 $163,407 - $236,796
7,077 Added 24.98%
35,411 $1.05 Million
Q1 2022

May 11, 2022
SELL
$26.91 - $47.15 $102,607 - $179,782
-3,813 Reduced 11.86%
28,334 $796,000
Q4 2021

Feb 10, 2022
SELL
$32.97 - $56.85 $94,986 - $163,784
-2,881 Reduced 8.22%
32,147 $1.48 Million
Q3 2021

Nov 12, 2021
BUY
$26.48 - $35.99 $927,541 - $1.26 Million
35,028 New
35,028 $1.15 Million

Others Institutions Holding ANIP

# of Institutions
241
Shares Held
20M
Call Options Held
19.9K
Put Options Held
12.8K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.54B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email